What is Samoan Aua (Microsorum grossum) used for medicinally?

Samoan Aua is used throughout Polynesia for a wide range of conditions including musculoskeletal injuries (sprains, fractures, bruises), fever and convulsions in children, skin conditions such as eczema and heat rash, respiratory complaints including cough and asthma, and as a gastrointestinal purgative. These applications are rooted in centuries of traditional Pacific Island ethnomedicine and are documented across the Society Islands, Samoa, the Cook Islands, and the Marquesas.

Is Microsorum grossum safe to use, and are there any risks?

Traditional knowledge explicitly warns that large quantities of Microsorum grossum are potentially abortifacient and multiple intoxications have been reported, indicating real dose-dependent toxicity. The plant is contraindicated in pregnancy, and due to the absence of formal clinical safety data, its use outside traditional supervised contexts carries unquantified risk; anyone considering use should consult a healthcare provider.

What are the active compounds in Microsorum grossum?

The primary documented bioactive compounds in Microsorum grossum are phytoecdysteroids, most notably 20-hydroxyecdysone, a polyhydroxylated steroid analog found in the fronds and rhizomes. This compound has been shown in laboratory studies to up-regulate the cytoprotective enzyme Heme Oxygenase 1 (HO1) in human skin cells, driving its antioxidant and photoprotective properties.

Does Microsorum grossum have any proven skin benefits?

In vitro studies using human dermal fibroblasts demonstrate that an ecdysteroid-enriched fraction of Microsorum grossum can up-regulate HO1, protecting skin cells from UV-induced oxidative stress, and can prevent premature cellular senescence caused by repeated UV exposure. However, these findings are based on cell culture research only and have not yet been confirmed in human clinical trials, so proven clinical skin benefits in living people remain to be established.

How is Samoan Aua traditionally prepared and used?

Traditionally, M. grossum is prepared in several ways depending on the intended use: fronds (preferably without spores) are boiled into bathing preparations for skin conditions and fever; rhizomes are decocted alone or with other plants for respiratory and gastrointestinal applications; and roots are macerated in coconut milk for topical use in women's health practices in the Marquesas Islands. No standardized supplement form or validated dosage protocol exists outside of traditional practice.

What does the research show about Microsorum grossum's photoprotection mechanisms?

Clinical studies demonstrate that the ecdysteroid fraction in Microsorum grossum activates HO1 (heme oxygenase-1) in human dermal fibroblasts, a key enzyme that provides intracellular antioxidant defense against UV-induced photodamage and immune suppression. This mechanism suggests the ingredient may help protect skin cells from sun damage at the molecular level. The evidence is primarily derived from in vitro studies on human skin cells, indicating promising potential for photoprotective applications.

Can Microsorum grossum help prevent premature skin aging at the cellular level?

In vitro research shows that Microsorum grossum extract can prevent premature senescence (aging) of human skin fibroblasts, the cells responsible for collagen and structural protein production. By inhibiting cellular aging pathways, this fern may help maintain skin elasticity and firmness over time. However, these findings are currently limited to laboratory studies and would require clinical trials to confirm benefits in living humans.

Who would benefit most from using Microsorum grossum for skin health?

Individuals concerned with sun damage, photoaging, and maintaining youthful skin appearance may benefit most from Microsorum grossum, given its documented UV-protective and anti-senescence properties in skin cells. Those with occupational sun exposure or those looking for additional photoprotection beyond sunscreen could be ideal candidates. However, it should complement rather than replace conventional sun protection strategies and dermatologist-recommended skincare regimens.

Samoan Aua

Microsorum grossum fronds and rhizomes contain phytoecdysteroids—principally 20-hydroxyecdysone—which up-regulate Heme Oxygenase 1 (HO1) in human dermal fibroblasts, conferring protection against UV-induced oxidative stress and cellular senescence. In vitro studies on human skin cells demonstrate that an ecdysteroid-enriched fraction of the fern can prevent premature UV-induced senescence, though no human clinical trials have yet confirmed these effects in vivo.

Category: Pacific Islands Evidence: 1/10 Tier: Preliminary

Origin & History

Microsorum grossum is a tropical fern native to the Pacific Islands, with a distribution spanning Samoa, French Polynesia (including the Society Islands and Marquesas), the Cook Islands, and Hawaii, where it is known locally as lauaʻe. It grows in humid, shaded forest understory environments, typically colonizing rocky substrates, tree trunks, and moist soil at low to mid elevations across the Pacific basin. The plant has not been subject to formal commercial cultivation and is predominantly harvested from wild populations for traditional medicinal use throughout Polynesia.

Historical & Cultural Context

Microsorum grossum occupies a prominent position in Pacific Island ethnomedicine and is recognized as one of the most medicinally important plants throughout the Society Islands and broader Polynesian cultural sphere, with documented use extending across Samoa, French Polynesia, the Cook Islands, and Hawaii. In Hawaiian tradition, the closely related usage under the name lauaʻe associates the fern with fragrance, spiritual protection, and healing, and the plant features in lei-making and ceremonial contexts alongside its medicinal applications. In the Marquesas Islands, rhizome preparations in coconut milk reflect a sophisticated understanding of fat-soluble extraction of bioactive compounds from plant material, a preparation logic consistent with the lipophilic character of phytoecdysteroids. The plant's breadth of traditional applications—spanning orthopedic, dermatological, pediatric, gynecological, and respiratory conditions—across geographically separated island groups suggests deep pre-contact knowledge transmission and a long history of empirical therapeutic use throughout Polynesia.

Health Benefits

- **Photoprotection of Skin Cells**: The ecdysteroid fraction of M. grossum up-regulates HO1 in human dermal fibroblasts, an enzyme central to intracellular antioxidant defense that specifically shields skin from UV-induced photodamage and immune suppression.
- **Anti-Senescence Activity**: In vitro evidence shows the fern extract can prevent premature senescence of human skin fibroblasts repeatedly exposed to UV irradiation, suggesting potential applications in anti-aging dermatology.
- **Musculoskeletal Injury Support**: Traditional 'fati' preparations using M. grossum are applied throughout the Society Islands for broken bones, sprains, shock, and bruising, pointing to possible anti-inflammatory or tissue-repair-supportive properties not yet mechanistically characterized.
- **Antipyretic and Neurocalming Use**: Bathing preparations from the fronds are employed across Polynesia to reduce fever and calm convulsions and nervousness, particularly in children, reflecting a traditional role in thermoregulatory and nervous system support.
- **Gastrointestinal Purgative Action**: The plant is used as a purgative in French Polynesia and the Cook Islands; the identity of the responsible laxative phytochemicals has not been isolated in peer-reviewed literature but may relate to resinous or saponin-like constituents in the rhizome.
- **Dermatological Soothing**: Spore-free frond baths are prepared to treat heat rashes and eczema across several island groups, consistent with the in vitro finding of oxidative stress protection in skin cells.
- **Respiratory Symptom Relief**: Roots combined with other medicinal plants are used in traditional Polynesian practice to treat cough and asthma, though the active bronchodilatory or anti-inflammatory compounds in these preparations remain uncharacterized.

How It Works

The primary documented mechanism of Microsorum grossum involves its phytoecdysteroid content, particularly 20-hydroxyecdysone, which up-regulates expression of Heme Oxygenase 1 (HO1)—a cytoprotective enzyme that catalyzes the degradation of pro-oxidant free heme into biliverdin, carbon monoxide, and free iron, thereby reducing intracellular reactive oxygen species and protecting against UV-induced photodamage. HO1 induction also confers photoimmunoprotection by limiting the suppression of local cutaneous immune responses following UV exposure. The ecdysteroid fraction has been shown in human dermal fibroblast models to interrupt the cellular senescence cascade triggered by cumulative UV radiation, likely by attenuating oxidative signaling upstream of p21 and p53 pathway activation, though these downstream targets have not been fully elucidated for this species. The broader traditional uses—anti-inflammatory, antipyretic, purgative—implicate additional phytochemical classes (potentially flavonoids, tannins, or terpenoids) whose molecular targets remain to be systematically identified.

Scientific Research

The body of formal scientific literature on Microsorum grossum is narrow and confined predominantly to in vitro research; no peer-reviewed human clinical trials with defined sample sizes, randomized controls, or quantified clinical endpoints have been published as of the available evidence base. The most substantive published work involves cell culture studies using human dermal fibroblasts, demonstrating HO1 up-regulation and prevention of UV-induced premature senescence by the plant's ecdysteroid fraction—findings that, while mechanistically plausible, have not been replicated in animal models or translated to clinical populations. Ethnobotanical surveys from French Polynesia and adjacent island groups provide systematic documentation of traditional applications across multiple communities, lending the plant cultural legitimacy but not clinical validation. The evidence base as a whole is best characterized as preclinical and ethnopharmacological, with a substantial research gap between observed in vitro activity and any verified therapeutic outcome in humans.

Clinical Summary

No human clinical trials investigating Microsorum grossum as a therapeutic intervention have been identified in the peer-reviewed literature. The most directly translatable evidence comes from in vitro studies using human dermal fibroblast cell lines exposed to repeated UV irradiation, where ecdysteroid-enriched fractions demonstrated statistically observable reductions in markers of cellular senescence; however, specific effect sizes, p-values, and concentration-response data are not fully detailed in publicly available sources. Ethnobotanical documentation across multiple Pacific Island societies provides consistent cross-cultural reports of efficacy for musculoskeletal, dermatological, and febrile conditions, which constitutes convergent observational evidence but cannot substitute for controlled trial data. Confidence in therapeutic recommendations for any specific human indication is low given the exclusive reliance on in vitro and traditional-use evidence.

Nutritional Profile

Microsorum grossum has not been subject to systematic proximate or micronutrient analysis in the peer-reviewed literature, and quantitative nutritional composition data are not available. The plant's primary documented bioactive phytochemicals are phytoecdysteroids, particularly 20-hydroxyecdysone, a polyhydroxylated steroid hormone analog; concentration data for these compounds in the fronds or rhizomes have not been published in accessible sources. Ferns in the Polypodiaceae family generally contain phenolic compounds, flavonoids, and tannins that may contribute to antioxidant activity, but species-specific quantification for M. grossum is absent. Bioavailability of 20-hydroxyecdysone via oral consumption is expected to be moderate based on data from related phytoecdysteroid-containing species, though no pharmacokinetic studies specific to this plant have been conducted.

Preparation & Dosage

- **Traditional Frond Bath (Dermatological/Antipyretic)**: Fresh fronds, preferably without spores, are boiled or steeped in water and the resulting bath preparation is applied topically or used as a full-body soak; no standardized volume or concentration has been established.
- **Rhizome Decoction (Respiratory/Gastrointestinal)**: Roots are boiled, sometimes in combination with other medicinal plants, and the decoction consumed orally; quantities vary by practitioner and island tradition with no validated dose range.
- **Rhizome in Coconut Milk (Women's Health, Marquesas)**: Roots are macerated or infused in coconut milk for intimate topical use; preparation details are culturally transmitted and not formally standardized.
- **'Fati' Poultice (Musculoskeletal)**: Plant material is prepared as a topical compress or poultice applied to sprains, fractures, and bruises in the Society Islands tradition.
- **No Standardized Supplement Form Available**: No commercial extract, capsule, tincture, or standardized supplement formulation of M. grossum with defined 20-hydroxyecdysone content has been established in the Western supplement market as of available evidence.
- **Caution on Quantity**: Traditional knowledge explicitly warns that large quantities are potentially abortive, and multiple intoxications have been reported; no maximum safe dose has been formally established.

Synergy & Pairings

In traditional Polynesian medicine, M. grossum roots are combined with other indigenous plants in multi-ingredient preparations for respiratory conditions including cough and asthma, suggesting empirically derived synergistic formulations, though the specific companion plants and their interactive mechanisms have not been pharmacologically characterized. The phytoecdysteroid 20-hydroxyecdysone found in M. grossum has shown synergistic antioxidant effects with vitamin C and other phenolic antioxidants in cell culture models involving related ecdysteroid-containing species, suggesting a potential rational stack for photoprotective applications. No commercially validated or clinically tested synergistic combination products containing M. grossum extract are currently documented in the literature.

Safety & Interactions

Traditional knowledge across multiple Pacific Island societies explicitly identifies large doses of Microsorum grossum as potentially abortifacient, making the plant contraindicated during pregnancy; this is a well-documented ethnopharmacological warning and not merely theoretical. Several cases of intoxication attributed to this plant have been reported in traditional-use contexts, indicating a real, dose-dependent toxicity threshold, though the specific toxic compounds, threshold doses, and clinical features of toxicity are not characterized in available peer-reviewed literature. No formal drug interaction studies exist; however, given the plant's documented purgative action and the hormonal structural similarity of 20-hydroxyecdysone to steroid hormones, theoretical caution is warranted in individuals taking hormonal medications, anticoagulants, or immunosuppressants. Lactating women, children outside traditional supervised applications, and individuals with known liver or kidney impairment should avoid self-administration given the absence of safety data and documented risk of adverse events at uncontrolled doses.